Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
139,3 EUR | -0,60% | -0,03% | -1,67% |
21/05 | Nanobiotix draagt Fase 3 hoofd-hals kanker studie sponsorschap over | MT |
21/05 | Valneva benoemt nieuwe Chief Scientific Officer | MT |
Omzet 2024 * | 88,37 mld. 81,41 mld. | Omzet 2025 * | 90,78 mld. 83,63 mld. | Marktkapitalisatie | 364 mld. 335 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 22,04 mld. 20,3 mld. | Nettowinst (verlies) 2025 * | 23,09 mld. 21,27 mld. | EV/omzet 2024 * | 4,04 x |
Nettoliquiditeiten 2024 * | 7 mld. 6,45 mld. | Nettoliquiditeiten 2025 * | 21,07 mld. 19,41 mld. | EV/omzet 2025 * | 3,78 x |
K/w-verhouding 2024 * |
16,8
x | K/w-verhouding 2025 * |
15,9
x | Werknemers | 131.900 |
Dividendrendement 2024 * |
3,19% | Dividendrendement 2025 * |
3,33% | Vrij verhandelbaar | 77,08% |
Recentste transcriptie over Johnson & Johnson
1 dag | -0,60% | ||
1 week | -0,03% | ||
Lopende maand | +2,22% | ||
1 maand | +1,52% | ||
3 maanden | -4,43% | ||
6 maanden | +1,19% | ||
Lopend jaar | -1,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01-01-89 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01-01-98 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25-04-19 |
D. Davis
BRD | Director/Board Member | 72 | 19-06-14 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22-10-09 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
21-05-24 | 139,3 | -0,60% | 2 790 |
20-05-24 | 140,2 | -0,95% | 1 763 |
17-05-24 | 141,5 | +0,55% | 2 767 |
16-05-24 | 140,7 | +0,92% | 3 882 |
15-05-24 | 139,5 | +0,06% | 3 787 |
uitgestelde koers Xetra, 21 mei 2024 om 17:35 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,78% | 705 mld. | |
+32,82% | 583 mld. | |
+19,94% | 332 mld. | |
+5,14% | 291 mld. | |
+16,64% | 238 mld. | |
-4,13% | 210 mld. | |
+10,63% | 209 mld. | |
+9,32% | 169 mld. | |
-0,80% | 162 mld. |